SOCS1 and neoplasm: SOCS1 and SOCS3 proteins were initially described as onco-suppressors, being silenced in many tumors (42) as consequence of hypermethylation of their promoters or mutations influencing proliferation, differentiation and survival of immune cells controlling tumor expansion (107).